Once removed, drug makers will no longer be able to include phenylephrine in products for the temporary relief of nasal ...

A deviated septum occurs when you have two different-sized nasal passageways which can cause one-sided congestion.

The U.S. Food and Drug Administration has proposed to remove oral phenylephrine, widely used in cold and cough syrups, as an ...

An extensive review determined that the ingredient, oral phenylephrine, doesn’t actually relieve nasal congestion.

Share on Facebook Share on Twitter The Food and Drug Administration (“FDA”) said on Thursday that they will seek to pull the ...

A Phase III trial with the companies’ monoclonal antibody in patients with chronic rhinosinusitis with nasal polyps met its ...

The US Food and Drug Administration has proposed to remove oral phenylephrine, widely used in cold and cough syrups.

It was added to cold and flu remedies in the 1990s when another ingredient went behind the counter over illicit meth lab concerns.

Sinus infections (also known as sinusitis) strike more than 30 million Americans each year. And if you’re one of them, you’re ...

Amgen (NASDAQ:AMGN) and AstraZeneca today announced positive top-line results from the Phase 3 WAYPOINT trial in patients ...

Amgen (AMGN) and AstraZeneca's (AZN) asthma therapy Tezspire hits main goals in the Phase 3 trial for chronic rhinosinusitis ...

Amgen (AMGN) and AstraZeneca (AZN) announced top-line results from the Phase 3 WAYPOINT trial in patients with chronic rhinosinusitis with ...